All articles by Sarah Houlton – Page 4
-
BusinessLilly loses arbitration over Canadian patents
Firm had sought recompense under the Nafta trade agreement
-
BusinessCrispr patent ruling breaks deadlock
Both sides claim victory as board rules patents do not interfere with each other
-
FeatureUS water crisis
The problems that the US city of Flint had with its water were just the first drip in a wider problem, finds Sarah Houlton
-
BusinessCholesterol drug withdrawn in patent dispute
Ruling that Regeneron’s Praluent antibody infringes Amgen’s Repatha patent could stifle innovation
-
BusinessPharmaceutical industry roundup of 2016
Controversial approvals and price clashes characterised 2016 in pharma
-
-
BusinessAll part of the service
Simon Hirst, founder of contract research organisation Sygnature, is the 2016 Chemistry World entrepreneur of the year
-
BusinessClinical trial death highlights hazards
Pain drug trial has left one dead and five hospitalised in France, with little indication as to the cause of the problems
-
FeatureThe natural food dye revolution
As consumers turn their backs on artificial food colorants, food scientists learn how to work with natural alternatives. Sarah Houlton investigates
-
-
CareersBoston, US
With more pharma and biotech companies moving in to the Boston-Cambridge hub, Sarah Houlton asks what it’s like for the chemists involved
-
BusinessFemale sexual desire drug approved
Concerns raised over efficacy, side effects and use of advocacy campaigning to influence regulatory decisions
-
BusinessCompanies clamour for CAR-T
Engineered immune cell therapies show promise in early cancer trials, prompting firms to compete for a foothold in the field
-
-
FeatureFighting food fraud
After recent food scandals, analytical chemistry is more in demand than ever to reassure consumers, as Sarah Houlton discovers
-
-
-
CareersNuclear energy's next generation
Sarah Houlton meets the graduates training for careers in the nuclear industry
-
FeatureChemistry in bloom
Sarah Houlton discovers the chemistry among the specimens at many botanical gardens
-
BusinessRoche to buy InterMune for respiratory boost
$8.3bn deal gives Roche a leading position in pulmonary fibrosis